SeedIL Ventures

SeedIL Ventures invests from Tel Aviv at seed and Series A with checks of $250K to $1M, connecting high-net-worth investors with Israeli medtech and digital health founders targeting global scaling. The firm operates with a syndication-oriented model and tends to make small checks count by participating in rounds led by larger institutional investors. Founders pitching SeedIL are usually building companies with clear international commercialization ambitions rather than ones aimed primarily at the Israeli domestic market.

The thesis focuses on digital health and medical devices and medtech. SeedIL is most interested in companies whose technical or clinical work is differentiated and whose founders have credible plans for taking their product into the United States, Europe, or Asia. The portfolio leans toward B2B and clinical-product companies rather than consumer wellness, and the firm engages with founders who can articulate global market dynamics and the regulatory paths that come with them. Pre-revenue companies are welcome where the underlying technology and team justify the bet.

Check sizes of $250K to $1M position SeedIL as a participating co-investor in seed and Series A rounds, frequently alongside larger Israeli and international VCs. The geographic focus is Israel, with portfolio companies generally building toward Western and global markets. Founders should expect SeedIL to be most useful as an additional engaged investor on a cap table where another firm is leading, and they should treat its value as coming from the network of high-net-worth investors and operating advisors it brings, rather than from check scale or formal governance support.

The team includes investors with backgrounds spanning Israeli technology venture, healthcare operating roles, and capital aggregation from international high-net-worth networks. That structure gives portfolio companies access to advisors and follow-on investors who can support international commercial expansion and additional rounds, which often matters more for early-stage Israeli companies than the dollars alone.

SeedIL Ventures’ working style is collaborative and syndicate-friendly. The firm typically takes observer roles rather than full board seats and engages on commercial strategy, particularly around international expansion and follow-on fundraising. SeedIL co-invests with Israeli VCs, international healthcare-focused funds, and family offices, and has supported portfolio companies through subsequent financings and partnerships with global strategic players. Founders building Israeli medtech or digital health companies with serious global ambitions, and who want an additional engaged investor with access to high-net-worth syndicates and international networks, will find SeedIL a useful addition to a round. Founders looking for a single lead investor or large primary check will need to anchor the round elsewhere and treat SeedIL as a complementary co-investor.